CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany Apr 29, 2025 8:30am EDT
CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab Feb 24, 2025 8:30am EST
CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories Feb 06, 2025 8:30am EST
CytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies with SMC Laboratories Oct 30, 2024 8:30am EDT
CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development Oct 08, 2024 8:30am EDT
CytoDyn Announces Abstract that Highlights Leronlimab’s Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques Oct 07, 2024 11:05am EDT
